Argentina In Vitro Diagnostics Market Trends

Factors such as increasing cancer prevalence coupled with research studies are expected to increase the market growth. According to the International Agency for Research on Cancer's report for 2020, there were around 130,878 new instances of cancer diagnosed in Argentina in both sexes 2020, and there were also approximately 70,074 cancer-related deaths. Additionally, according to the same source, there have been around 358,327 cancer cases in Argentina over the past five years. According to the survey, prostate cancer was most common in males, while breast cancer was most common in women across the nation. As per the same source, there are around 15,895 cases of colon cancer reported in Argentina for the year 2020. The same source also reported that the 5-year prevalence of colon cancer in Argentina is 33,509. All the healthcare-related criteria under analysis revealed decreases, according to a study titled "The Impact of the COVID-19 Pandemic on Cancer Care in the Public Health Subsector, Province of Santa Fe, Argentina," which was published in Ecancer Medical Science in July 2021. The impact was more noticeable in screening, though; there were between 56% and 87% fewer operations done overall. There was a 26% decline in diagnosis. Treatment was the study's variable with the least impact, dropping by 3%. However, post the pandemic the screening process is likely to increase which is expected to increase the market growth. 

Thus, the abovementioned factors are expected to increase the market growth.